Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / COM PAR
-
Total 13F shares
-
300,006
-
Share change
-
+40,380
-
Total reported value
-
$2,244,000
-
Price per share
-
$7.40
-
Number of holders
-
13
-
Value change
-
+$306,309
-
Number of buys
-
6
-
Number of sells
-
4
Institutional Holders of IMMUCELL CORP /DE/ - COM PAR (ICCC) as of Q4 2015
As of 31 Dec 2015,
IMMUCELL CORP /DE/ - COM PAR (ICCC) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
300,006 shares.
The largest 10 holders included
HealthInvest Partners AB, RENAISSANCE TECHNOLOGIES LLC, SHUFRO ROSE & CO LLC, Essex Financial Services, Inc., MORGAN STANLEY, GRT CAPITAL PARTNERS L.L.C., Minerva Advisors LLC, UBS Group AG, BANK OF AMERICA CORP /DE/, and Walleye Trading LLC.
This page lists
13
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.